Jaypee Brothers
In Current Chapter
In All Chapters
X
Clear
X
GO
Normal
Sepia
Dark
Default Style
Font Style 1
Font Style 2
Font Style 3
Less
Normal
More
An Introduction to Genetics and Fetal Medicine
Deepika Deka, Narendra Malhotra
SECTION 1: UNDERSTANDING GENETICS
CHAPTER 1:
An Introduction to Fetal Medicine
FETAL CONGENITAL MALFORMATIONS
Common Preventable Congenital Disorders
Polygenic-Cleft Lip and Palate, Lethal Malformations
Mendelian Inheritance
PRENATAL DIAGNOSIS
Genetic Screening Test versus Prenatal Diagnostic Test
Preconception Care
Pregnancy Care
Prenatal Genetic Screening Investigations
At Risk Pregnancies Identifiable During Pregnancy
FETAL EXAMINATION
PRENATAL DIAGNOSTIC PROCEDURES
AMNIOCENTESIS29–33
Common Indications
CHORION VILLUS SAMPLING (CVS)34–36
Common Indications
CORDOCENTESIS/FETALCORD BLOOD SAMPLING37–39
Common Indications
FETAL THERAPY
Medical Fetal Therapy
Surgical Fetal Therapy45–48
FOLLOW-UP
Fetal Therapy or Surgery
Planned Delivery
CHAPTER 2:
Genetic Counseling for Obstetricians
GENETIC COUNSELING1–3
Nondirectiveness in Genetic Counseling
Psychological Issues
Guilt and Blame
Reproductive Decision Making
Impact on the Extended Family
Bereavement
Long-term Support and Follow-up
Indications for Genetic Counseling
Steps in an Antenatal Case Management1,2
History
Family History
History of any Genetic Disorders in the Family
Specialized Investigation
DNA Based Tests (Molecular Tests)
Chromosomal Analysis (Cytogenetics)
Biochemical Testing
GENETIC COUNSELING FOR VARIOUS GENETIC DISORDERS
Chromosomal Disorders
Multifactorially Inherited Disorders
Single Gene Defects
X Linked Disorders
Autosomal Recessive Disorders
Autosomal Dominant Disorders
Role of Obstetricians in Management of Patients with Genetic Disorder and Antenatal Detection of Malformation
Special Problems in Genetic Counseling
Culture Failure
KEY POINTS TO REMEMBER
CONCLUSION
CHAPTER 3:
Periconceptional Care
INTRODUCTION
SCOPE AND GOALS OF PCC
PERICONCEPTIONAL COUNSELORS
PCC COMPONENTS
WEIGHT DISTURBANCES
CHRONIC MEDICAL DISORDERS
Diabetes Mellitus
Epilepsy
Heart Disease
Hypertension
Renal Disease
Systemic Lupus Erythematosus
Psychiatric Illness
Genetic Disease and Congenital Malformations
PERICONCEPTIONAL FOLIC ACID
PERICONCEPTIONAL VITAMINS
CHAPTER 4:
Recurrent Pregnancy Loss
GENERAL BACKGROUND
ETIOLOGY
Spontaneous Miscarriage
Recurrent Miscarriage
CHROMOSOMAL ABERRATIONS
Numerical Abnormalities
Aneuploidy
Polyploidy
Structural Abnormalities
Translocations
Chromosomal Abnormalities in Recurrent Miscarriages
Fetal Chromosomal Abnormalities
Parental Chromosomal Abnormalities
Diagnosis of Chromosomal Abnormalities
Genetic Counseling and Management
Management of Pregnancy in Parental Chromosomal Anomaly
Psychosocial Issues
INTRODUCTION
Role of Conventional Sperm Parameters
Sperm Mitochondria DNA Nucleotide Alterations and Correlation with Oxidative Stress
Oxidative Stress (OS)
Sperm DNA Damage
Factors which can Prevent Oxidative Stress Induced DNA Damage
CONCLUSION
CHAPTER 5:
Teratogens and Radiation Exposure
INTRODUCTION
IMPORTANCE OF THE PROBLEM
ASSESSMENT OF TERATOGENICITY OF AN AGENT
CATEGORIES OF TERATOGENIC EXPOSURE
Intrauterine Infections (Refer Chapter 11)
Ionizing Radiations
Drugs and Chemical Agents
Teratogenic Effects of Anticonvulsants
Teratogenic Effects of Anticoagulants and Anticoagulation During Pregnancy
Counseling for Teratogenic Effects
Prenatal Diagnosis
Preconception Care
SECTION 2: PRENATAL SCREENING AND DIAGNOSIS
CHAPTER 6:
Prenatal Biochemical Screening
BURDEN OF DISEASE
AIM OF SCREENING PROGRAM
First Trimester Screening
Nuchal Translucency
Biochemical Markers
Combined First Trimester Ultrasound and Biochemical Screening
Advantages of First Trimester Combined Screening
Second Trimester Biochemical Screening
Screening for Neural tube defects
Other Screening Strategies5
Integrated Screening
Sequential Screening
Contingent Screening
Screening in Twin Pregnancies
Limitations of the Screening Program
CONCLUSION
CHAPTER 7:
Ultrasound
CHROMOSOMAL DEFECTS
Maternal Age
Nuchal Translucency
Fetal Heart Rate (FHR)
Serum Biochemistry
New Ultrasound Markers
Nasal Bone (Fig. 7.10)
Facial Angle (Fig. 7.11)
Ductus Venosus Flow (Fig. 7.12)
Tricuspid Flow (Fig. 7.13)
MAJOR FETAL ABNORMALITIES
TWIN PREGNANCIES
Determination of Chorionicity
SCREENING FOR PRE-ECLAMPSIA
PRACTICAL SCHEMATIC ANALYSIS FOR FETAL ANOMALIES EXTRAFETAL EVALUATION
Liquor Amnii
Quantity
Amniotic Bands
Umbilical Cord
Number of Vessels
Origin and Insertion
FETAL EVALUATION
Choroid Plexii (Figs 7.29 and 7.30)
Cerebellum (Figs 7.31 and 7.32)
Cisterna Magna (Fig. 7.33)
Nuchal Skin (Figs 7.34 and 7.35)
Fetal Orbits and Face
Fetal Spine
Fetal Thorax
Fetal Heart
Fetal Abdomen
Fetal Skeleton
Fetal Biometry
COLOR DOPPLER AND 3D IN PREDICTING FETAL WELLBEING
Significance of Notch
DOPPLER VELOCIMETRY IN HIGH-RISK PREGNANCIES
CONCLUSION
CURRENT AND FUTURE TRENDS
CLINICAL APPLICATIONS
First Trimester Studies
Second Trimester Fetal Anomalies
Fetal Face
Umbilical Cord
Volume Measurements
Limitations of 3D US
FUTURE DIRECTIONS
DEFINITION AND BACKGROUND
SONOGRAPHIC MARKERS FOR DOWN'S SYNDROME (TRISOMY 21)
Overview of Markers
Major Markers
Minor Markers
SENSITIVITY OF MARKER DETECTION
SIGNIFICANCE OF INDIVIDUAL MARKERS
TRISOMY 18 (EDWAR'D SYNDROME)
TRISOMY 13 (PATAU'S SYNDROME)
TURNER'S SYNDROME (XO)
TRIPLOIDY
GENETIC SONOGRAPHY AFTER FIRST TRIMESTER SCREENING
CHAPTER 8:
Invasive Techniques
INDICATIONS
PROCEDURE
Abdominal
Transcervical Route
Postprocedure Care
COMPLICATIONS
PREGNANCY LOSS
ACCURACY OF CVS CYTOGENETIC RESULTS
CONCLUSION
INTRODUCTION
ORIGIN OF AMNIOTIC FLUID
FUNCTIONS OF AMNIOTIC FLUID
CONSTITUENTS OF AMNIOTIC FLUID
INDICATIONS FOR AMNIOCENTESIS
TIMING OF AMNIOCENTESIS
COMPLICATIONS
INTRAPROCEDURAL COMPLICATIONS
Needle Injury
Blood Contamination
Orthopedic Abnormalities
POSTPROCEDURAL COMPLICATIONS
Procedure Related Miscarriages
Premature Rupture of Membranes
Respiratory Abnormalities
CONCLUSION
INTRODUCTION
PROCEDURE
INDICATIONS
Hematological Diseases
Fetal Structural Abnormality
Intrauterine Infection
Nonimmune Hydrops (NIH)
Intrauterine Growth Restriction (IUGR)
Fetal Therapy
COMPLICATIONS
CONCLUSION
CHAPTER 9:
Laboratory Techniques in Prenatal Diagnosis of Genetic Disorders
CHROMOSOMAL DISORDERS
Indications for Chromosomal Analysis
Molecular Cytogenetics
Fluorescent in situ Hybridization (FISH) (Fig. 9.2)
Quantitative Fluorescent PCR
Prenatal Cytogenetic Diagnosis
Single Gene Disorders
Testing for Single Gene Disorders
MUTATION DETECTION
Diagnostic Testing
Carrier Testing
Presymptomatic Testing
THALASSEMIAS
Clinical Presentation
Carrier Detection
Prenatal Diagnosis
Cordocentesis
Antenatal Thalassemia Screening and Fetal Diagnosis
Preimplantation Genetic Diagnosis
HEMOPHILIA A AND B
Management and Associated Problems
FACTOR VIII GENE POLYMORPHISMS
FACTOR IX GENE POLYMORPHISMS
Molecular Genetic Testing
Clinical Testing
LINKAGE ANALYSIS IN HEMOPHILIA A AND B
Testing Strategy
Testing of Relatives at Risk
Prenatal Testing
Chorionic Villus Sampling (CVS)
Percutaneous Umbilical Blood Sampling (PUBS)
Genetic Counseling
Perceptions of Hemophilia
Mode of Inheritance
Risk to Family Members
Parents of a Male Proband
Sibs of a Male Proband
Offspring of a Male Proband
Other Family Members of the Proband
Carrier Detection
Related Genetic Counseling Issues
Family Planning
DNA Banking
SECTION 3: INTRAUTERINE GROWTH RESTRICTION
CHAPTER 10:
Maternal-fetal Work-up and Management in Intrauterine Growth Restriction (IUGR)
INTRODUCTION
Definitions
Pathophysiology
IUGR vs SGA
CLINICAL SIGNIFICANCE AND INCIDENCES
ASYMMETRIC vs SYMMETRIC GROWTH RETARDATION
MATERNAL FETAL RISK FACTORS
FETAL CAUSES
Diagnosis and Surveillance
Criteria for Diagnosis
Screening the Fetus for Growth Restriction
Diagnostic and Assessment Tools for Evaluation of IUGR. (Table 10.1)
Management of IUGR
STEPS OF MANAGEMENTS
General Lines
Tests to Assess Fetal Wellbeing and Growth
Timing of Delivery
Labor and Delivery
Prognosis
Selective Intrauterine Growth Restriction (SIUGR)
Future Directions and Prevention
CONCLUSION
SECTION 4: FETAL DISEASES AND THEIR MANAGEMENT
CHAPTER 11:
Fetal Infections
INCIDENCE
MATERNAL FETAL TRANSMISSION
CONGENITAL TORCH COMPLEX
Clinical Features of Maternal Infection6
Diagnosis of Maternal Infection
Avidity-testing to Pinpoint Timing of Maternal TORCH Infections during Pregnancy21
Diagnosis of Fetal Infection
Fetal Therapy and Management
Rubella
Cytomegalovirus (CMV)
Perinatal Herpes Simplex Virus (HSV)
CHAPTER 12:
Rh Disease
INTRODUCTION
HISTORY
PATHOPHYSIOLOGY
ROUTINE Rh SCREENING AND OBSTETRIC HISTORY
Rh Titer
Rh Typing of Fetus
FACTORS INFLUENCING Rh(D) IMMUNIZATION
Rh Prophylaxis
Effect of ABO Incompatibility
Rh Status of Father
MANAGEMENT OF Rh ISO-IMMUNIZED PREGNANCIES
Technique
Ultrasound Assessment
INVASIVE TESTING OF THE FETUS
Serial Amniocentesis
Cordocentesis
Fetal Blood Transfusion
PROCEDURE
Intraperitoneal Fetal Blood Transfusion (IPT)
Intravascular Fetal Blood Transfusion (IVT)
Combined IVT and IPT
Neonates
CHAPTER 13:
Biochemical Defects
INTRODUCTION
Working Classification of Metabolic Errors
BIOCHEMICAL DEFECTS WITH RELEVANCE TO FETAL MEDICINE
Anabolic Errors (Fetal)—Examples
Catabolic Errors (Newborn)—Examples
Pathogenesis
Fetal Presentation of IEM
Fetomaternal Link in Metabolic Disorders
IDENTIFYING METABOLIC ERROR IN NEWBORN
Case Illustration
Newborn Screening
Prenatal Invasive Procedure
IMPORTANCE OF CONFIRMING DIAGNOSIS
Case Illustration
Difficulties in Prenatal Diagnosis
Assessing Risk is the First Step Towards PND
Principles of Management
Perimortem Sample Collection
Specimens to be Collected for the Investigation of the Dead Fetus
Support Group
ILLUSTRATION OF VARIOUS INBORN ERRORS OF METABOLISM (FIGS 13.6 TO 13.13)
ACKNOWLEDGMENTS
CHAPTER 14:
Fetal Reduction
INTRODUCTION
BACKGROUND
MEDICOLEGAL ISSUES AND PSYCHOLOGICAL IMPACT
PROCEDURE
METHODS
Prerequisites
Informed Consent
Antibiotics and Tocolysis
Preoperative Ultrasonography
TECHNIQUE
Transcervical Aspiration
Disadvantages of the Procedures
Transabdominal Needling
Transvaginal Needling
OTHER METHODS
POTASSIUM CHLORIDE
COMPLICATIONS
FAILED REDUCTION
SELECTIVE REDUCTION
STUDIES ON FETAL REDUCTION
CONCLUSION
CHAPTER 15:
Fetal Gastrointestinal Tract Defects
INTRODUCTION
U/S APPEARANCES OF THE NORMAL FETAL GASTROINTESTINAL TRACT
Esophagus and Stomach
Small Bowel and Colon
GASTROINTESTINAL OBSTRUCTION
Sonophysiological Considerations
Esophageal Atresia
Obstetric Management
Duodenal Atresia
Prognosis
Obstetric Management
Small Bowel Atresia
U/S Diagnosis
Midgut Volvulus
Small Bowel Obstruction due to Meconium Ileus
Atypical Causes for Small Bowel Dilatation
Megacystis Microcolon Intestinal Hypoperistalsis Syndrome
Congenital Chloride Diarrhea
Large Bowel Obstruction
THE HEPATOBILIARY SYSTEM AND THE SPLEEN
Sonoanatomy
Sonopathology
Hepatic Pathology
Cholelithiasis
Biliary Atresia
Fetal Hepatosplenomegaly
CONCLUSION
SECTION 5: NEONATAL MANAGEMENT
CHAPTER 16:
Neonatal Surgery for Congenital Malformations and Prognosis
NONGENITOURINARY MALFORMATIONS
Congenital Diaphragmatic Hernia
Management
Surgery
Prognosis
Esophageal Atresia with or without Tracheoesophageal Fistula (Figs 16.2A and B)
Antenatal Findings
Surgery
Prognosis
Omphalocele and Gastroschisis (Figs 16.3 and 16.4)
Omphalocele (Fig. 16.3)
Management
Surgery
Prognosis
Gastroschisis (Fig. 16.4)
Management
Surgery
Prognosis
Intestinal Atresias
Management
Surgery
Prognosis
Jejunoileal Stenosis and Atresia
Diagnosis
Management
Surgery
Prognosis
Colonic Atresia
Management
Surgery
Outcome
Hirschsprung's Disease (Fig. 16.5)
Surgery
Procedures for Long-Segment Hirschsprung Disease
Prognosis
Anorectal Malformations (Figs 16.6 to 16.8)
Management
Surgery
Prognosis
GENITOURINARY MALFORMATIONS
Pelviureteric Junction Obstruction (PUJO) (Fig. 16.9)
Prognosis
Posterior Urethral Valves (PUV) (Fig. 16.10)
Prenatal Diagnosis
Prognosis
Bladder Exstrophy-epispadias Complex (Fig. 16.11)
Surgery
Cloaca (Fig. 16.8)
Surgery
Prognosis
Urogenital Sinus
Surgery
Congenital Anomalies of the Vagina
Vaginal Atresia
Abnormalities of Fusion
Vertical Fusion
Lateral Fusion
Hydrocolpos and Hydrometrocolpos (Fig. 16.17)
Surgery
Vaginal Replacement Procedures
Cloacal Exstrophy (Fig. 16.18)
Prolapsed Ureterocele
Urethral Prolapsed (Fig. 16.19)
Disorders of Sex Development
Spina Bifida (Fig. 16.22)
CHAPTER 17:
Fetal/Neonatal Autopsy
INTRODUCTION
Technique, Protocol
External Measurements
Gross External Examination
Gross and Microscopic Examination
Incisions
Skin Incisions Varierty
OPTIONAL SPECIAL STUDIES
Specimen Collection
Cytogenetic Studies
Histology
ACKNOWLEDGMENTS
SECTION 6: FUTURE OPTIONS
CHAPTER 18:
Preimplantation Genetic Diagnosis
INTRODUCTION
Indications4
Couples with a High-risk of Transmitting an Inherited Condition
Pregenetic Screening (PGS)
Advanced Maternal Age
Repeated Spontaneous Abortion
Mitochondrial Disorders
Ethically Difficult Indications
Nondisclosure PGD for Huntington's Disease
Recent Application of PGD
PGD for Sex Selection
PGD for Nonmedical Traits
Technical Aspects of Preimplantation Genetic Diagnosis
Obtaining Embryos for Preimplantation Genetic Diagnosis
BIOPSY PROCEDURES
Polar Body Biopsy
Cleavage-stage Biopsy (Blastomere Biopsy)
Blastocyst Biopsy
GENETIC ANALYSIS TECHNIQUES
Fluorescent In Situ Hybridization (FISH)
Polymerase Chain Reaction (PCR)
Problems Faced During Genetic Analysis
Establishing a Diagnosis
Preimplantation Genetic Haplotyping
Embryo Transfer and Cryopreservation of Surplus Embryos
Ethical Issues8
Regulatory Authority
CONCLUSION
CHAPTER 19:
Noninvasive Prenatal Diagnosis from Fetal DNA in Maternal Circulation
FETAL NUCLEATED CELLS IN MATERNAL BLOOD
Cell Free Fetal DNA (CFF DNA) in Maternal Circulation
Principles of Circulating Fetal DNA Analysis
Clinical Applications
CONCLUSION
SECTION 7: ETHICAL AND LEGAL ISSUES
CHAPTER 20:
Legal and Ethical Issues of Prenatal Diagnosis and Therapy
INTRODUCTION
BIOETHICAL PRINCIPLES
Respect for Persons
Beneficence
Nonmaleficence
Justice
Confidentiality
Veracity
ETHICAL ISSUES OF PRENATAL DIAGNOSIS
Views of opponents of Prenatal Diagnostic Testing and Abortion of the Affected Fetus
Views of Proponents of Prenatal Diagnostic Tests and Abortion
ETHICS OF THE MATERNAL/FETAL RELATIONSHIP
ETHICAL ISSUES OF FETAL THERAPY
ETHICAL GUIDELINES FOR GENETIC COUNSELING
Ethical Concerns of Human Genome Project
FIGO GUIDELINES FOR PRENATAL TESTING
CHAPTER 21:
Amendment of the MTP Act
TERMINATION OF PREGNANCY
DEFINITION OF MTP
Medical Abortion
Indication for MTP as per Act
Qualification of Doctors Required Under MTP Act
FOR APPROVAL OF A PLACE
Composition and Tenure of District Level Committee
REQUIREMENT FOR APPROVAL OF A PLACE
Exclusion
Punishment
Power to Make Regulations
Protection of Action Taken in Good Faith
SECTION 8: MISCELLANEOUS
CHAPTER 22:
Nonimmune Hydrops Fetalis
INTRODUCTION
CLASSIFICATION
PATHOPHYSIOLOGY
DIAGNOSIS AND ANTENATAL MANAGEMENT
ULTRASOUND EXAMINATION
ETIOLOGY1,4,8,10,11,13,15,17–19,21,23,25,26
Fetal—Focal Abnormality
Cardiac 20–25%
Intrathoracic Lesions or 8–10% Masses
Gastrointestinal 1%
Hepatic 1%
Renal 2–3%
Vascular/Tumors 2–4%
Fetal—Generalized Abnormality
Infectious causes 1–8%
Skeletal Dysplasia 4%
Metabolic Disorders 1%
Chromosomal Disorders
Fetal Anemia 10–27%
Syndromes 8–9%
Twinning 4–8%
Placental/Umbilical 2–6%
Maternal <1%
DIAGNOSTIC APPROACH TO THE FETUS WITH HYDROPS26
FETAL THERAPY
General Considerations
Before the Age of Viability
After the Age of Viability
Neonatal Management of Hydrops Fetalis
Investigation of a Stillbirth or Neonatal Death with Hydrops Fetalis
OUTCOME
CONCLUSION
CHAPTER 23:
Ultrasound Diagnosis of Intrauterine Fetal Growth Restriction (FGR)
INTRODUCTION
DEFINITION OF IUGR/FGR
ETIOLOGY
UTERINE ARTERY DOPPLER MEASUREMENT
OTHER FETAL VESSELS
INDEX
TOC
Index
×
Chapter Notes
Save
Clear